{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:07:15Z","timestamp":1794625635631,"version":"4.9.1"},"reference-count":30,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NINDS\/NIH","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Harvard Center for Mendelian Genomics","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000090","name":"CDMRP","doi-asserted-by":"crossref","award":["W81XWH-20-1-0219"],"award-info":[{"award-number":["W81XWH-20-1-0219"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UM1 HG008900"],"award-info":[{"award-number":["UM1 HG008900"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["R01 HG009141"],"award-info":[{"award-number":["R01 HG009141"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Broad Institute of MIT","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2021\/06739-4"],"award-info":[{"award-number":["2021\/06739-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of the upper and lower motor neurons with varying ages of onset, progression and pathomechanisms. Monogenic childhood-onset ALS, although rare, forms an important subgroup of ALS. We recently reported specific\n                      <jats:italic>SPTLC1<\/jats:italic>\n                      variants resulting in sphingolipid overproduction as a cause for juvenile ALS. Here, we report six patients from six independent families with a recurrent, de novo, heterozygous variant in\n                      <jats:italic>SPTLC2<\/jats:italic>\n                      c.778G&gt;A [p.Glu260Lys] manifesting with juvenile ALS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical examination of the patients along with ancillary and genetic testing, followed by biochemical investigation of patients\u2019 blood and fibroblasts, was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All patients presented with early-childhood-onset progressive weakness, with signs and symptoms of upper and lower motor neuron degeneration in multiple myotomes, without sensory neuropathy. These findings were supported on ancillary testing including nerve conduction studies and electromyography, muscle biopsies and muscle ultrasound studies. Biochemical investigations in plasma and fibroblasts showed elevated levels of ceramides and unrestrained de novo sphingolipid synthesis. Our studies indicate that\n                      <jats:italic>SPTLC2<\/jats:italic>\n                      variant [c.778G&gt;A, p.Glu260Lys] acts distinctly from hereditary sensory and autonomic neuropathy (HSAN)-causing\n                      <jats:italic>SPTLC2<\/jats:italic>\n                      variants by causing excess canonical sphingolipid biosynthesis, similar to the recently reported\n                      <jats:italic>SPTLC1<\/jats:italic>\n                      ALS associated pathogenic variants. Our studies also indicate that serine supplementation, which is a therapeutic in\n                      <jats:italic>SPTLC1<\/jats:italic>\n                      and\n                      <jats:italic>SPTCL2<\/jats:italic>\n                      -associated HSAN, is expected to exacerbate the excess sphingolipid synthesis in serine palmitoyltransferase (SPT)-associated ALS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SPTLC2<\/jats:italic>\n                      is the second SPT-associated gene that underlies monogenic, juvenile ALS and further establishes alterations of sphingolipid metabolism in motor neuron disease pathogenesis. Our findings also have important therapeutic implications: serine supplementation must be avoided in SPT-associated ALS, as it is expected to drive pathogenesis further.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2023-332132","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T13:21:00Z","timestamp":1700832060000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Recurrent de novo\n                    <i>SPTLC2<\/i>\n                    variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3250-6755","authenticated-orcid":false,"given":"Safoora B","family":"Syeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Museer A","family":"Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Mohassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donkervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinki","family":"Munot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2419","authenticated-orcid":false,"suffix":"Jr","given":"Marcondes C","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Eli","family":"Galarza-Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eckenweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Asamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita D","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Lakhotia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry B","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Reghan","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Hornemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G","family":"B\u00f6nnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2024011107550749000_95.2.103.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.203"},{"key":"2024011107550749000_95.2.103.2","doi-asserted-by":"crossref","unstructured":"Mejzini R , Flynn LL , Pitout IL , et al . ALS genetics, mechanisms, and therapeutics: where are we now Front Neurosci 2019;13:1310. doi:10.3389\/fnins.2019.01310","DOI":"10.3389\/fnins.2019.01310"},{"key":"2024011107550749000_95.2.103.3","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"2024011107550749000_95.2.103.4","doi-asserted-by":"crossref","unstructured":"Lehky T , Grunseich C . Juvenile amyotrophic lateral sclerosis: a review. Genes (Basel) 2021;12:1935. doi:10.3390\/genes12121935","DOI":"10.3390\/genes12121935"},{"key":"2024011107550749000_95.2.103.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01346-1"},{"key":"2024011107550749000_95.2.103.6","doi-asserted-by":"crossref","first-page":"159359","DOI":"10.1016\/j.bbalip.2023.159359","article-title":"SPTLC1 p.Leu38Arg, a novel mutation associated with childhood ALS","volume":"1868","author":"Lone","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2024011107550749000_95.2.103.7","doi-asserted-by":"publisher","DOI":"10.1039\/C8NP00019K"},{"key":"2024011107550749000_95.2.103.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00553-7"},{"key":"2024011107550749000_95.2.103.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-020-00551-9"},{"key":"2024011107550749000_95.2.103.10","doi-asserted-by":"crossref","unstructured":"Lone MA , Aaltonen MJ , Zidell A , et al . SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins. J Clin Invest 2022;132:e161908. doi:10.1172\/JCI161908","DOI":"10.1172\/JCI161908"},{"key":"2024011107550749000_95.2.103.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1516733112"},{"key":"2024011107550749000_95.2.103.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2018.09.013"},{"key":"2024011107550749000_95.2.103.13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24336"},{"key":"2024011107550749000_95.2.103.14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh712"},{"key":"2024011107550749000_95.2.103.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.092973"},{"key":"2024011107550749000_95.2.103.16","doi-asserted-by":"publisher","DOI":"10.1038\/85879"},{"key":"2024011107550749000_95.2.103.17","doi-asserted-by":"publisher","DOI":"10.1038\/85817"},{"key":"2024011107550749000_95.2.103.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.09.010"},{"key":"2024011107550749000_95.2.103.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2005.01.009"},{"key":"2024011107550749000_95.2.103.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2308-7"},{"key":"2024011107550749000_95.2.103.21","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2024011107550749000_95.2.103.22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.007291"},{"key":"2024011107550749000_95.2.103.23","doi-asserted-by":"crossref","unstructured":"Hjelmqvist L , Tuson M , Marfany G , et al . ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. Genome Biol 2002;3:RESEARCH0027. doi:10.1186\/gb-2002-3-6-research0027","DOI":"10.1186\/gb-2002-3-6-research0027"},{"key":"2024011107550749000_95.2.103.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C112.404012"},{"key":"2024011107550749000_95.2.103.25","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536"},{"key":"2024011107550749000_95.2.103.26","doi-asserted-by":"crossref","unstructured":"Fiorillo C , Capodivento G , Geroldi A , et al . The SPTLC1P. S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment. Neuropathol Appl Neurobiol 2022;48:e12842. doi:10.1111\/nan.12842","DOI":"10.1111\/nan.12842"},{"key":"2024011107550749000_95.2.103.27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbalip.2018.12.013","article-title":"1-Deoxysphingolipids","volume":"1864","author":"Lone","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2024011107550749000_95.2.103.28","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2536-09.2009"},{"key":"2024011107550749000_95.2.103.29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jns.12315","article-title":"Hereditary sensory and autonomic neuropathy type IC accompanied by upper motor neuron abnormalities and type II Juxtafoveal retinal Telangiectasias","volume":"24","author":"Triplett","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"2024011107550749000_95.2.103.30","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2023-332132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T10:56:54Z","timestamp":1704970614000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2023-332132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/jnnp-2023-332132"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2023-332132","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}